Medicus Pharma (MDCX) Net Cash Flow (2024 - 2025)

Medicus Pharma (MDCX) posted Net Cash Flow of $44355.0 for Q4 2025, down 98.77% quarter-over-quarter from $3.6 million in Q3 2025, and up 103.88% year-on-year from $21755.0 in Q4 2024.

Medicus Pharma (MDCX) Net Cash Flow (2024 - 2025) Analysis & Trends

Medicus Pharma (MDCX) has reported Net Cash Flow for 2 consecutive years, with $44355.0 the latest figure, recorded in Q4 2025.

  • Net Cash Flow for Q4 2025 came in at $44355.0, up 103.88% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.2 million (up 274.77% YoY), and the FY2025 annual result was $4.5 million, up 85.84% from the prior year.
  • Net Cash Flow was $44355.0 for Q4 2025 at Medicus Pharma, down from $3.6 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $7.9 million in Q2 2024 and troughed at -$3.1 million in Q3 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -2.05 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.00 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 4.17 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -1.53 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -9.27 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 75.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 544.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Medicus Pharma 6.91 Mn -1.69 Mn - 44,355.00

Historic Data

Download Data
DateValue
Dec 31, 2025 44,355.00
Dec 31, 2025 44,355.00
Sep 30, 2025 3.61 Mn
Sep 30, 2025 3.61 Mn
Jun 30, 2025 5.69 Mn
Jun 30, 2025 5.69 Mn
Mar 31, 2025 -181,893.00
Mar 31, 2025 -181,893.00
Dec 31, 2024 -1.14 Mn
Dec 31, 2024 -1.14 Mn
Sep 30, 2024 -3.10 Mn
Sep 30, 2024 -3.10 Mn
Jun 30, 2024 7.87 Mn
Jun 30, 2024 7.87 Mn
Mar 31, 2024 -1.18 Mn
Mar 31, 2024 -1.18 Mn